(Q90181901)

English

Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis

scientific article published on 01 November 2019

Statements

Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit